ELAVL1 and idiopathic pulmonary fibrosis: In addition, blocking autophagic flow mediated by linc00941/lncIAPF-ELAVL1/HuR promotes fibroblast differentiation, providing new targets and effective therapeutic strategies for autophagy-based treatments for idiopathic pulmonary fibrosis [18].